Stuart M Levitz MD
Professor, Medicine, University Massachusetts Medical School
Join to view full profile
55 Lake Ave NWorcester, MA 01655
Phone+1 774-441-8230
Fax+1 508-334-3428
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Stuart Levitz, MD is an infectious disease specialist in Worcester, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is a Professor at University Massachusetts Medical School.
Education & Training
Boston University Medical CenterFellowship, Infectious Disease, 1982 - 1984
New York University School of MedicineClass of 1979
Certifications & Licensure
MA State Medical License 1982 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 13 citationsImmunological correlates of protection mediated by a whole organism,, vaccine deficient in chitosan.Charles A Specht, Ruiying Wang, Lorena V N Oliveira, Maureen M Hester, Christina Gomez
Mbio. 2024-08-14 - 12 citationsProtection against experimental cryptococcosis elicited by Cationic Adjuvant Formulation 01-adjuvanted subunit vaccines.Ruiying Wang, Lorena V N Oliveira, Maureen M Hester, Diana Carlson, Dennis Christensen
Plos Pathogens. 2024-07-01 - Protection against experimental cryptococcosis elicited by Cationic Adjuvant Formulation 01-adjuvanted subunit vaccines.Ruiying Wang, Lorena V N Oliveira, Maureen M Hester, Diana Carlson, Dennis Christensen
Biorxiv. 2024-04-28
Press Mentions
New Antifungal Medications Are Sorely NeededJanuary 18th, 2022- Valley Fever Vaccine for Dogs Shows Promising Results, First Step Toward Human TrialsNovember 5th, 2021
- How COVID-19 Created a Perfect Storm for a Deadly Fungal Infection in IndiaJune 22nd, 2021
Grant Support
- Fungal Antigen Resources for Development of Vaccines and DiagnosticsUNIV OF MASSACHUSETTS MED SCH WORCESTER2025–2030
- A subunit Cryptococcus vaccineUNIV OF MASSACHUSETTS MED SCH WORCESTER2022–2027
- Preclinical studies of a Cryptococcus vaccine for AIDS patientsDUKE UNIVERSITY2016–2026